Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
The ETS gene family is frequently involved in chromosome translocations that cause human cancer, including prostate cancer, leukemia, and sarcoma. However, the mechanisms by which oncogenic ETS proteins, which are DNA-binding transcription factors, target genes necessary for tumorigenesis is not well understood. Ewing's sarcoma serves as a paradigm for the entire class of ETS-associated tumors because nearly all cases harbor recurrent chromosomal translocations involving ETS genes. The most common translocation in Ewing's sarcoma encodes the EWS/FLI oncogenic transcription factor. We used whole genome localization (ChIP-chip) to identify target genes that are directly bound by EWS/FLI. Analysis of the promoters of these genes demonstrated a significant over-representation of highly repetitive GGAA-containing elements (microsatellites). In a parallel approach, we found that EWS/FLI uses GGAA microsatellites to regulate the expression of some of its target genes including NR0B1 , a gene required for Ewing's sarcoma oncogenesis. The microsatellite in the NR0B1 promoter bound EWS/FLI in vitro and in vivo and was both necessary and sufficient to confer EWS/FLI regulation to a reporter gene. Genome wide computational studies demonstrated that GGAA microsatellites were enriched close to EWS/FLI-up-regulated genes but not down-regulated genes. Mechanistic studies demonstrated that the ability of EWS/FLI to bind DNA and modulate gene expression through these repetitive elements depended on the number of consecutive GGAA motifs. These findings illustrate an unprecedented route to specificity for ETS proteins and use of microsatellites in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nine ETS proteins have been assayed for genome-wide occupancy by either promoter microarrays (ETS1, GABPA, ELF1, ELK1, EWS-FLI1, and SPI1) (132–135) or high-throughput sequencing (GABPA, ETS1, ERG, FLI1, EWS-ERG, EWS-FLI1, SPI1, SPDEF, ETV1, and ELF1) (29, 62, 65, 136–140).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
In the citing paper
“Of these two classes of target sequences, only genes near the microsatellite repeats correlate with expression changes associated with transformation, including NROB1 (133) and GSTM4 (186).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
In the citing paper
“ChIP-chip and ChIP-Seq have identified the genomic regions bound by the most common ETS fusion proteins in Ewing’s sarcoma, EWS-FLI1 and EWS-ERG (62, 133, 137).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
In the citing paper
“In fact, four or more repeats are necessary for EWS-FLI1 transcriptional activation in reporter assays, and two EWS-FLI1 monomers bind to this four-motif array in biochemical assays (Figure 7) (133, 137, 187).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
Citations
Cites
Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
Bailey, T. L., & Elkan, C. (1994) · PubMed · Cited by 5,806
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
US Department of Health and Human Services; National Cancer Institute (1999) · PsycEXTRA Dataset · doi:10.1037/e407432005-001 · Cited by 1,947
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 2×
“Ewing’s sarcoma is a highly malignant solid tumor of children and young adults that usually harbors a recurrent chromosomal translocation, t(11;22)(q24;q12), that encodes the EWS/FLI fusion oncoprotein (10).”
BackgroundThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · cited 1×
“Most members of the ETS family bind to DNA sequences containing a GGAA (or in some cases, GGAT) core motif, with sequences flanking the GGAA core contributing to the affinity and specificity of the interaction (3, 6, 7).”
BackgroundCentre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574
Self-citationMay, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
Self-citationETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469
Research works printed but not linked: 2
- 10.1128/mcb.13.12.7393-7398.1993 · doi:10.1128/mcb.13.12.7393-7398.1993 · Paper page
- ME Gillespie A structural and genetic investigation of DNA binding by the murine Ets-1 Ets domain a winged HTH transcription factor. (University of Utah Salt Lake City PhD thesis. (1998).
Cited by
Imaging dynamic and selective low-complexity domain interactions that control gene transcription
Chong, S., Dugast-Darzacq, C., Liu, Z., Dong, P., Dailey, G. M., Cattoglio, C., Heckert, A., Banala, S., Lavis, L., Darzacq, X., et al. (2018) · Science · doi:10.1126/science.aar2555 · Cited by 966
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
“However, consistent with earlier results for FLI1 (Gangwal et al, 2008), analysis of EWS/ERG and EWS/FLI1 peak sequences resulted in identification of a motif resembling GGAA microsatellite repeats (Supplementary Figure S8A).”
Phosphorylation-Regulated Binding of RNA Polymerase II to Fibrous Polymers of Low-Complexity Domains
Kwon, I., Kato, M., Xiang, S., Wu, L., Theodoropoulos, P., Mirzaei, H., Han, T., Xie, S., Corden, J. L., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.10.033 · Cited by 547
“ChIP-chip experiments have given evidence that when the LC domain of EWS is linked to the FLI DNA-binding domain, it binds in living cells to microsatellites carrying iterative repeats of the tetranucleotide sequence GGAA (Gangwal et al., 2008).”
BackgroundGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Self-citationCancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Boulay, G., Sandoval, G. J., Riggi, N., Iyer, S., Buisson, R., Naigles, B., Awad, M. E., Rengarajan, S., Volorio, A., McBride, M. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.036 · Cited by 470
“…EWS-FLI1 is able to activate a large set of target genes by operating as a pioneer factor at GGAA microsatellite repeats and inducing active enhancers de novo starting from a closed chromatin conformation (Gangwal et al., 2008; Guillon et al., 2009; Patel et al., 2012; Riggi et al., 2014).”
Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.004 · Cited by 445
“GGAA repeats have been implicated previously in Ewing sarcoma on the basis of their association with open chromatin and proximity to some activated genes (Gangwal et al., 2008; Guillon et al., 2009).”
BackgroundErkizan, H. V., Kong, Y., Merchant, M., Schlottmann, S., Barber-Rotenberg, J. S., Yuan, L., Abaan, O. D., Chou, T.-H., Dakshanamurthy, S., Brown, M. L., et al. (2009) · Nature Medicine · doi:10.1038/nm.1983 · Cited by 452
“To further support YK-4-279 as a functional inhibitor of EWS-FLI1, we transfected COS7 cells with EWS-FLI1 and NR0B1 reporter-luciferase plasmid (containing EWS-FLI1 regulatory GGAA element”
Advances in sarcoma genomics and new therapeutic targets
Taylor, B. S., Barretina, J., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3087 · Cited by 427
“The numbers of bound genomic regions in such studies have varied widel”
Discovering Hematopoietic Mechanisms through Genome-wide Analysis of GATA Factor Chromatin Occupancy
Fujiwara, T., O'Geen, H., Keles, S., Blahnik, K., Linnemann, A. K., Kang, Y.-A., Choi, K., Farnham, P. J., & Bresnick, E. H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.001 · Cited by 350
“GGAATGGAATG resides in microsatellite repeats (Gangwal et al., 2008) and contains the Ets binding motif GGAA (Sharrocks, 2001).”
BackgroundPromiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
“In contrast, the mouse Nr0b1 promoter lacks the GGAA-microsatellite, and cannot be induced by EWS/FLI in murine NIH3T3 cells (59).”
BackgroundSelf-citationETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Oh, S., Shin, S., & Janknecht, R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.002 · Cited by 249
“Indeed, it was found that EWS-FLI1, but not FLI1, can also bind to GGAA microsatellite repeats in cells, and transcription of genes regulated by such microsatellites might be important for Ewing tumor genesis [13,83,84].”
BackgroundChildren's Oncology Group's 2013 blueprint for research: Bone tumors
Gorlick, R., Janeway, K., Lessnick, S., Randall, R. L., Marina, N., & on behalf of the COG Bone Tumor Committee (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24429 · Cited by 226
Self-citationGuillon, N., Tirode, F., Boeva, V., Zynovyev, A., Barillot, E., & Delattre, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004932 · Cited by 218
“Moreover, EWS-FLI1 direct interaction with these repeated elements was validated by gel shift assays [33].”
BackgroundInfluentialTuning levels of low-complexity domain interactions to modulate endogenous oncogenic transcription
Chong, S., Graham, T. G. W., Dugast-Darzacq, C., Dailey, G. M., Darzacq, X., & Tjian, R. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.007 · Cited by 207
A Molecular Function Map of Ewing's Sarcoma
Kauer, M., Ban, J., Kofler, R., Walker, B., Davis, S., Meltzer, P., & Kovar, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005415 · Cited by 191
“9% of the down-regulated genes in GS1 are represented among directly bound genes in a recently published EWS-FLI1 ChIP-on chip study [15].”
BackgroundResultInfluentialShort tandem repeats bind transcription factors to tune eukaryotic gene expression
Horton, C. A., Alexandari, A. M., Hayes, M. G. B., Marklund, E., Schaepe, J. M., Aditham, A. K., Shah, N., Suzuki, P. H., Shrikumar, A., Afek, A., et al. (2023) · Science · doi:10.1126/science.add1250 · Cited by 189
“Although previous reports have identified repeated instances of motif and motif-like sequences that bind TFs and thereby alter gene expression ( 20 , 134 , 135 ), these observations are well explained by simple position weight matrix models ( 136 – 138 ) that do not predict the enhanced binding to…”
BackgroundRecent advances in the molecular pathogenesis of Ewing's sarcoma
Toomey, E. C., Schiffman, J. D., & Lessnick, S. L. (2010) · Oncogene · doi:10.1038/onc.2010.205 · Cited by 191
“The CAV1 promoter contains a GGAA microsatellite that is occupied by EWS/FLI in vivo (Gangwal et al., 2008), is highly expressed in Ewing’s sarcoma tumors, and promotes tumor growth in mouse xenograft models of Ewing’s sarcoma (Tirado et al., 2006).”
BackgroundInfluentialSelf-citationMolecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets
Lessnick, S. L., & Ladanyi, M. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130237 · Cited by 190
“During the process of understanding the regulation of NR0B1 gene expression by EWSFLI1, a unique EWS-FLI1 response element was identified: GGAA-containing microsatellites (28).”
BackgroundInfluentialSelf-citationChimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Grünewald, T. G. P., Bernard, V., Gilardi-Hebenstreit, P., Raynal, V., Surdez, D., Aynaud, M.-M., Mirabeau, O., Cidre-Aranaz, F., Tirode, F., Zaidi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3363 · Cited by 186
Sankar, S., Theisen, E. R., Bearss, J., Mulvihill, T., Hoffman, L. M., Sorna, V., Beckerle, M. C., Sharma, S., & Lessnick, S. L. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0072 · Cited by 173
“BCL2L1 primers were used as normalization controls (38).”
Self-citationMechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
Sankar, S., Bell, R., Stephens, B., Zhuo, R., Sharma, S., Bearss, D. J., & Lessnick, S. L. (2013) · Oncogene · doi:10.1038/onc.2012.525 · Cited by 167
Self-citationMinireview: Role Of Orphan Nuclear Receptors in Cancer and Potential as Drug Targets
Safe, S. H., Jin, U.-H., Hedrick, E., Reeder, A., & Lee, S. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1291 · Cited by 164
Aynaud, M.-M., Mirabeau, O., Gruel, N., Grossetête, S., Boeva, V., Durand, S., Surdez, D., Saulnier, O., Zaïdi, S., Gribkova, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.049 · Cited by 171
Non‐B DNA conformations as determinants of mutagenesis and human disease
Bacolla, A., & Wells, R. D. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20507 · Cited by 152
“The most recurrent translocation in Ewing’s sarcoma encodes ESW/FLI, an oncogenic transcription factor which, upon translocation, acquires high affinity binding properties for tandem GGAA repeats [97].”
BackgroundA Solid-State Conceptualization of Information Transfer from Gene to Message to Protein
Kato, M., & McKnight, S. L. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044700 · Cited by 143
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 169
“Furthermore, NROB1 and GSTM4, two ETS fusion target genes required for the Ewing’s transformed phenotype, contain microsatellites bearing tandem repeats of the GGAA core ETS binding sequence (Gangwal et al., 2008; Luo et al., 2009).”
BackgroundErratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
Sankar, S., Bell, R. N., Stephens, B. J., Zhuo, R., Sharma, S., Bearss, D. J., & Lessnick, S. L. (2016) · Oncogene · doi:10.1038/onc.2016.142 · Cited by 139
Self-citationDr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family
Kovar, H. (2010) · Sarcoma · doi:10.1155/2011/837474 · Cited by 154
“An alternative intriguing mechanism may involve the binding of EWS-FLI1 to microsatellites outside of promoter regions even at distances of several megabases from the transcriptional start sites [141–143].”
BackgroundLoci-specific phase separation of FET fusion oncoproteins promotes gene transcription
Zuo, L., Zhang, G., Massett, M., Cheng, J., Guo, Z.-C., Wang, L., Gao, Y., Li, R., Huang, X., Li, P.-L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21690-7 · Cited by 123
Wang, Q.-F., Wu, G., Mi, S., He, F., Wu, J., Dong, J., Luo, R. T., Mattison, R., Kaberlein, J. J., Prabhakar, S., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324699 · Cited by 132
Eckert, K. A., & Hile, S. E. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20499 · Cited by 145
“The length of a pure [GGAA]n allele in specific promoters directly affects binding of the EWS/FL1 oncogenic transcription factor, thereby modulating target gene expression during oncogenesis [16].”
BackgroundShah, S. N., Hile, S. E., & Eckert, K. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3049 · Cited by 115
“Importantly, transactivation increased with each additional unit of GGAA, and differences in microsatellite size and sequence have been suggested to be a factor determining susceptibility to Ewing's sarcoma (23).”
Patel, M., Simon, J. M., Iglesia, M. D., Wu, S. B., McFadden, A. W., Lieb, J. D., & Davis, I. J. (2012) · Genome Research · doi:10.1101/gr.125666.111 · Cited by 114
“Although FLI1 can bind the tetranucleotide repeats both in vivo and in vitro, it fails to show activity at these repeats in reporter-based assays (Gangwal et al. 2008, 2010) suggesting that FLI1 requires the cooperation of other sequence-specific transcription factors to activate transcription.”
BackgroundResultInfluentialZhang, H., Hughes, C. S., Li, W., He, J., Surdez, D., El-Naggar, A. M., Cheng, H., Prudova, A., Delaidelli, A., Negri, G. L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1690 · Cited by 124
McKinsey, E., Parrish, J. K., Irwin, A. E., Niemeyer, B. F., Kern, H. B., Birks, D. K., & Jedlicka, P. (2011) · Oncogene · doi:10.1038/onc.2011.197 · Cited by 116
“The negative control (Neg) is an average of the ChIP fold-enrichment at the Albumin and Bcl promoters, subsequently set to 1; ChIP of the NR0B1 promoter is the positive control (Gangwal et al., 2008).”
Minas, T. Z., Surdez, D., Javaheri, T., Tanaka, M., Howarth, M., Kang, H., Han, J. J., Han, Z., Sax, B., Kream, B. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9388 · Cited by 116
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
Tang, S.-W., Bilke, S., Cao, L., Murai, J., Sousa, F. G., Yamade, M., Rajapakse, V., Varma, S., Helman, L. J., Khan, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2112 · Cited by 103
“EWS-FLI1 is oncogenic by regulating multiple target genes through binding to typical ETS core consensus sites or GGAA microsatellites (14, 15).”
BackgroundSurdez, D., Zaïdi, S., Grossetête, S., Laud-Duval, K., Ferre, A. S., Mous, L., Vourc’h, T., Tirode, F., Pierron, G., Raynal, V., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.001 · Cited by 112
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis
Marques, M. R., Simpson, D. R., Ngok, S. P., Nieves, B., Ron, C., Siprashvili, Z., Vaka, D., Breese, M. R., Crompton, B. D., Alexe, G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72124 · Cited by 105
“Direct activation of gene expression by EWS-FLI1 occurs via binding to a consensus motif near promoters or by binding to a distal microsatellite repeat (57, 58).”
Kinsey, M., Smith, R., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1540 · Cited by 97
Self-citationLuo, W., Gangwal, K., Sankar, S., Boucher, K. M., Thomas, D., & Lessnick, S. L. (2009) · Oncogene · doi:10.1038/onc.2009.262 · Cited by 93
“of binding GGAA-microsatellites in vitro as well as in vivo (Gangwal and Lessnick, 2008; Gangwal et al., 2008).”
BackgroundMethodInfluentialSelf-citationHarlow, M. L., Maloney, N., Roland, J. T., Navarro, M. J. G., Easton, M. K., Kitchen-Goosen, S. M., Boguslawski, E. A., Madaj, Z., Johnson, B. K., Bowman, M. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0568 · Cited by 93
“NR0B1 is a well-established EWS-FLI1 target gene whose expression is driven by binding of the fusion protein to a GGAA microsatellite contained within the gene's promoter (21).”
Robin, T. P., Smith, A., McKinsey, E., Reaves, L., Jedlicka, P., & Ford, H. L. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0086 · Cited by 91
“In addition, EWS/FLI1 often regulates critical target genes via GGAAmicrosatellite repeats (33, 43).”
InfluentialOrth, M. F., Surdez, D., Faehling, T., Ehlers, A. C., Marchetto, A., Grossetête, S., Volckmann, R., Zwijnenburg, D. A., Gerke, J. S., Zaïdi, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111761 · Cited by 92
Baldauf, M. C., Orth, M. F., Dallmayer, M., Marchetto, A., Gerke, J. S., Rubio, R. A., Kiran, M. M., Musa, J., Knott, M. M. L., Ohmura, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.20098 · Cited by 87
Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development
Vito, C. D., Riggi, N., Suvà, M.-L., Janiszewska, M., Horlbeck, J., Baumer, K., Provero, P., & Stamenkovic, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023592 · Cited by 85
“Moreover, despite the ability of EWS-FLI-1 to directly induce expression of cMyc, a known regulator of let-7 expression, recent evidence suggests that let-7a may also constitute a direct EWS-FLI-1 target gene [27], further supporting possible involvement of let-7a in ESFT development.”
BackgroundLin, L., Huang, M., Shi, X., Mayakonda, A., Hu, K., Jiang, Y., Guo, X., Chen, L., Pang, B., Doan, N., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1207 · Cited by 86
“Moreover, GGAA repeats, the established active EWS-FLI1 binding motif in Ewing sarcoma (4,6,24,25), were enriched in a much higher degree in superenhancer regions relative to typical-enhancer ones (Figure 3E).”
BackgroundTargeting chromatin complexes in fusion protein-driven malignancies
Brien, G. L., Stegmaier, K., & Armstrong, S. A. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0132-x · Cited by 86
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Related Tumors
Tsokos, M., Alaggio, R., Dehner, L. P., & Dickman, P. S. (2012) · Pediatric and Developmental Pathology · doi:10.2350/11-08-1078-pb.1 · Cited by 88
“EWS/FLI-1 regulates its target genes by binding to consensus ETS motifs [143,147,148] or specific microsatellite sequences [149,150] and also by mechanisms not involving DNA binding and possibly related to RNA processing [145].”
BackgroundJohnson, K. M., Mahler, N., Saund, R. S., Theisen, E. R., Taslim, C., Callender, N. W., Crow, J. C., Miller, K. R., & Lessnick, S. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701872114 · Cited by 90
“(Promega Corporation), as described previously (9, 11).”
BackgroundMethodResultInfluentialSelf-citationPinto, A., Dickman, P. S., & Parham, D. M. (2010) · Sarcoma · doi:10.1155/2011/856190 · Cited by 80
“Within the t(11;22), the chromosome breakpoint sites vary among 4 introns in EWS gene and six introns in the FLI1 gene and yield a large number of possible EWS-FLI1 fusion combinations [69].”
BackgroundInfluentialThe conservation landscape of the human ribosomal RNA gene repeats
Agrawal, S., & Ganley, A. R. D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207531 · Cited by 78
Grohar, P. J., Glod, J. W., Peer, C. J., Sissung, T. M., Arnaldez, F. I., Long, L., Figg, W. D., Whitcomb, P. O., Helman, L. J., & Widemann, B. C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3382-x · Cited by 81
“EWS–FLI1 induces gene expression by binding to regions of the genome called GGAA microsatellites and at the same time represses gene expression displacing other ETS family members from chromatin [8, 9].”
BackgroundGLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Joo, J., Christensen, L., Warner, K., States, L. J., Kang, H.-G., Vo, K. T., Lawlor, E. R., & May, W. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007608 · Cited by 78
“As such, these methods are likely to favor targets whose transcript levels are inherently high, such as those which may be strong direct EWS/FLI1 transcriptional targets [31].”
BackgroundVerbiest, M. A., Maksimov, M., Ye, J., Anisimova, M. O., Gymrek, M., & Sonay, T. B. (2022) · Journal of Evolutionary Biology · doi:10.1111/jeb.14106 · Cited by 90
“In another example, the aberrant EWSR1- FLI1 fusion protein formed in Ewing Sarcoma binds to GGAA repeats (Gangwal et al., 2008), converting them into de novo enhancers whose length is dependent on the length of the GGAA repeat tract (Riggi et al., 2014).”
BackgroundIdentification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor
Osgood, C. L., Maloney, N., Kidd, C. G., Kitchen-Goosen, S. M., Segars, L. E., Gebregiorgis, M., Woldemichael, G. M., He, M., Sankar, S., Lessnick, S. L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2624 · Cited by 73
“Therefore, we randomly selected a panel of EWS-FLI1 target genes to reflect both direct and indirect targets established by both genome-wide techniques and specific dedicated studies (see Supplementary Table S2 for evidence, S1 for primers)(11, 12, 24, 27-45).”
MethodSelf-citationCooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Musa, J., Cidre-Aranaz, F., Aynaud, M.-M., Orth, M. F., Knott, M. M. L., Mirabeau, O., Mazor, G., Varon, M., Hölting, T. L. B., Grossetête, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12071-2 · Cited by 66
Knott, M. M. L., Hölting, T. L. B., Ohmura, S., Kirchner, T., Cidre‐Aranaz, F., & Grünewald, T. G. P. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09839-9 · Cited by 72
“In turn, binding of EWSR1-FLI1 to such GGAA-mSats converts them into de novo enhancers and super-enhancers [16, 17].”
BackgroundMachiela, M. J., Grünewald, T. G. P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E., Rubío, R. A., Zaïdi, S., Grossetête, S., Ballet, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05537-2 · Cited by 76
Boulay, G., Volorio, A., Iyer, S., Broye, L. C., Stamenkovic, I., Riggi, N., & Rivera, M. N. (2018) · Genes & Development · doi:10.1101/gad.315192.118 · Cited by 79
“EWS-FLI1 binding is most clearly associated with enhancer activation at a large set of GGAAmicrosatellite repeats where the fusion protein behaves as a pioneer factor to induce chromatin opening and the deposition of histone modifications associated with active enhancer elements (H3K4me1 and H3K27ac) (Gangwal et al. 2…”
BackgroundThe molecular pathogenesis of Ewing sarcoma
Mackintosh, C., Madoz‐Gúrpide, J., Ordóñez, J. L., Osuna, D., & Herrero‐Martín, D. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.9.11511 · Cited by 86
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Theisen, E. R., Pishas, K. I., Saund, R. S., & Lessnick, S. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7124 · Cited by 70
“2, CAV1, GSTM4, and NR0B1 are regulated through EWS-FLI activity at nearby microsatellites, though none are currently candidates for therapeutic development [26, 30, 140-142].”
BackgroundSelf-citationEWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Cidre‐Aranaz, F., & Alonso, J. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00162 · Cited by 78
“The study of the mechanism through which EWS/FLI1 upregulates DAX-1 expression in Ewing sarcoma cells revealed an unexpected finding: EWS/FLI1 directly interacts with DAX-1 promoter through binding to a GGAArich sequence (9, 28).”
BackgroundSand, L. G. L., Szuhai, K., & Hogendoorn, P. C. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160716176 · Cited by 72
Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma
Gangwal, K., Close, D., Enriquez, C. A., Hill, C. P., & Lessnick, S. L. (2010) · Genes & Cancer · doi:10.1177/1947601910361495 · Cited by 67
“and B).(24) This result indicated that the EWS portion of the fusion is absolutely required for transcriptional activity but does not contribute to its DNA-binding function.”
InfluentialSelf-citationDownstream EWS/FLI1 - upstream Ewing's sarcoma
Kovar, H. (2010) · Genome Medicine · doi:10.1186/gm129 · Cited by 73
“The authors of the two studies [47,48] attempted to functionally validate the potential transcription enhancing activity of GGAA microsatellites in response to EWS/ FLI1 by testing multimers of the GGAA core motif in luciferase reporter assays [49].”
BackgroundResultKovar, H. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.947963 · Cited by 72
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins
Gollavilli, P. N., Pawar, A., Wilder-Romans, K., Natesan, R., Engelke, C. G., Dommeti, V. L., Krishnamurthy, P. M., Nallasivam, A., Apel, I. J., Xu, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0484 · Cited by 80
“Mechanistically, EWS/FLI1 preferentially binds to chromatin regions enriched for microsatellite GGAA repeats, induces the formation of de novo enhancers and super-enhancers marked by H3K27ac, and activates transcription of target genes (21, 40, 41).”
BackgroundIntrinsically disordered regions as facilitators of the transcription factor target search
Jonas, F., Navon, Y., & Barkai, N. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00816-3 · Cited by 80
“In fact, EWS–FLI1 transforms its new binding sites at GGAA microsatellites into de novo active enhancers for genes such as NR0B1 , which ultimately drives oncogenesis 71–75 .”
Johnson, K. M., Taslim, C., Saund, R. S., & Lessnick, S. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186275 · Cited by 70
Self-citationMarchetto, A., Ohmura, S., Orth, M. F., Knott, M. M. L., Colombo, M. V., Arrigoni, C., Bardinet, V., Saucier, D., Wehweck, F. S., Li, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16244-2 · Cited by 73
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
Dallmayer, M., Li, J., Ohmura, S., Rubío, R. A., Baldauf, M. C., Hölting, T. L. B., Musa, J., Knott, M. M. L., Stein, S., Cidre‐Aranaz, F., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1372-0 · Cited by 73
Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors
Lu, C., Tilan, J. U., Everhart, L. M., Czarnecka, M., Soldin, S. J., Mendu, D. R., Jeha, D., Hanafy, J., Lee, C. K., Sun, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224089 · Cited by 60
Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities
Anderson, J. L., Denny, C. T., Tap, W. D., & Federman, N. C. (2012) · Pediatric Research · doi:10.1038/pr.2012.54 · Cited by 55
“Myxoid liposarcoma t(12;16)(q13;q11) FUS-DDIT3”
BackgroundInfluentialEWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma
Tanner, J. M., Bensard, C., Wei, P., Krah, N. M., Schell, J. C., Gardiner, J. D., Schiffman, J. D., Lessnick, S. L., & Rutter, J. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0182 · Cited by 64
“Interestingly, while EF can affect known targets of FLI1 by binding to canonical FLI1-binding sites, it also influences expression of genes that are not targets of FLI1 or EWSR1 (4).”
BackgroundSelf-citationSankar, S., Tanner, J. M., Bell, R. N., Chaturvedi, A. P., Randall, R. L., Beckerle, M. C., & Lessnick, S. L. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00241-13 · Cited by 59
“ALB (31) and gene desert (33) primers were used as normalization controls.”
MethodSelf-citationTrabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
Harlow, M. L., Chassé, M. H., Boguslawski, E. A., Sorensen, K. M., Gedminas, J. M., Kitchen-Goosen, S. M., Rothbart, S. B., Taslim, C., Lessnick, S. L., Peck, A. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3511 · Cited by 55
“CRISPR/Cas9 elimination of this microsatellite eliminates NR0B1 expression and while both FLI1 and EWSFLI1 can bind this region, only EWS-FLI1 can activate NR0B1 expression (12, 37, 38).”
BackgroundSelf-citationSPOP and OTUD7A Control EWS–FLI1 Protein Stability to Govern Ewing Sarcoma Growth
Su, S., Chen, J., Jiang, Y., Wang, Y., Vital, T., Zhang, J., Laggner, C., Nguyen, K. T., Zhu, Z., Prevatte, A. W., et al. (2021) · Advanced Science · doi:10.1002/advs.202004846 · Cited by 70
Showpnil, I. A., Selich‐Anderson, J., Taslim, C., Boone, M. A., Crow, J. C., Theisen, E. R., & Lessnick, S. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac747 · Cited by 60
“GGAA-μsat binding by EWS/FLI is critical for its oncogenic function (Boulay et al., 2018; Gangwal et al., 2008; Johnson et al., 2017).”
BackgroundSelf-citationEwing sarcoma: a chronicle of molecular pathogenesis
Kim, S. K., & Park, Y.-K. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.05.008 · Cited by 56
EWS/FLI1 Oncogene Activates Caspase 3 Transcription and Triggers Apoptosis In vivo
Sohn, E. J., Li, K., Reidy, K. T., Beers, L. F., Christensen, B. L., & Lee, S. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1993 · Cited by 62
“To determine whether EWS/FLI1 is present on the human CASP3 promoter in vivo, we performed ChIP experiment using the anti-FLI1 antibody (C-19), which has been previously used for ChIP assay (18, 19).”
MethodGrohar, P. J., Kim, S., Rivera, G. O. R., Sen, N., Haddock, S., Harlow, M. L., Maloney, N., Zhu, J., O’Neill, M. J., Jones, T. L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.063 · Cited by 56
Apfelbaum, A. A., Wrenn, E. D., & Lawlor, E. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1044707 · Cited by 53
Is There a Predisposition Gene for Ewing's Sarcoma?
Randall, R. L., Lessnick, S. L., Jones, K. B., Gouw, L. G., Cummings, J. E., Cannon‐Albright, L., & Schiffman, J. D. (2010) · Journal of Oncology · doi:10.1155/2010/397632 · Cited by 54
“analyzed promoters of these target genes and described a significant overrepresentation of highly repetitive GGAA-containing elements (microsatellites) [77].”
BackgroundSelf-citationKedage, V., Selvaraj, N., Nicholas, T. R., Budka, J. A., Plotnik, J. P., Jerde, T. J., & Hollenhorst, P. C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.001 · Cited by 56
“…sarcoma, EWS-FLI1 activates transcription via cis-regulatory elements consisting of microsatellite repeats of the core ETS binding sequence, GGAA, and these GGAA repeats regulate the expression of genes that promote transformation and cancer cell survival (Gangwal et al., 2008; Riggi et al., 2014).”
BackgroundSelf-citationEWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
Fadul, J., Bell, R. N., Hoffman, L. M., Beckerle, M. C., Engel, M. E., & Lessnick, S. L. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.57 · Cited by 47
“We have previously shown that EWS/FLI is able to directly activate genes by binding GGAA microsatellite-rich promoters, while others demonstrated its binding with the transcriptional co-activator CBP/p300, or phosphorylation-dependent interaction with the C-terminal domain of RNA PolII itself [6-12].”
BackgroundSelf-citationPerry, J. A., Seong, B. K. A., & Stegmaier, K. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055710 · Cited by 42
“…operates as a pioneer factor by binding to GGAA microsatellite repeats in closed chromatin and inducing de novo enhancers that can then interact with promoters to activate the transcription of Ewing-specific genes (Gangwal et al. 2008,Gomez et al. 2016,Guillon et al. 2009, Riggi et al. 2014).”
BackgroundVohra, M., Sharma, A. R., Prabhu, N. B., & Padmalatha, S. (2020) · Public Health Genomics · doi:10.1159/000510253 · Cited by 56
Oncogenic ETS Factors in Prostate Cancer
Nicholas, T. R., Strittmatter, B. G., & Hollenhorst, P. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_18 · Cited by 58
Self-citationBCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
Wiles, E. T., Lui, B., Bell, R. N., & Lessnick, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059369 · Cited by 49
“did not show binding to the BCL11B promoter in our ChIP-chip data set [48].”
BackgroundSelf-citationHile, S. E., Wang, X., Lee, M. Y. W. T., & Eckert, K. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr889 · Cited by 44
“Microsatellite allele length polymorphisms have been implicated as genetic risk factors in human disease (4,5), and expansions at specific microsatellites are responsible for at least 40 inherited human disorders (6).”
BackgroundMicrosatellites are EWS/FLI response elements: Genomic "junk" is EWS/FLI's treasure
Gangwal, K., & Lessnick, S. L. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6892 · Cited by 45
Self-citationVibert, J., Saulnier, O., Collin, C., Petit, F., Borgman, K. J. E., Vigneau, J., Gautier, M., Zaïdi, S., Pierron, G., Watson, S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.019 · Cited by 45
Lu, D. Y., Ellegast, J. M., Ross, K. N., Malone, C. F., Lin, S., Mabe, N. W., Dharia, N. V., Meyer, A., Conway, A. S., Su, A. H., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01059-8 · Cited by 57
Self-citationUnstable Microsatellite Repeats Facilitate Rapid Evolution of Coding and Regulatory Sequences
Jansen, A., Gemayel, R., & Verstrepen, K. J. (2012) · Genome dynamics · doi:10.1159/000337121 · Cited by 43
Beck, R. J., Monument, M. J., Watkins, W. S., Smith, R. A., Boucher, K. M., Schiffman, J. D., Jorde, L. B., Randall, R. L., & Lessnick, S. L. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.04.004 · Cited by 55
“In our recent ChIP-chip dataset, a GGAA-microsatellite response element was observed in 12 of the top 134 (9%) direct EWS/FLI targets (21).”
BackgroundMethodInfluentialSelf-citationWidespread Chromatin Accessibility at Repetitive Elements Links Stem Cells with Human Cancer
Gomez, N. C., Hepperla, A. J., Dumitru, R., Simon, J. M., Fang, F., & Davis, I. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.011 · Cited by 41
“oncogenic transcriptional profile critical for maintaining tumorigenicity (Gangwal et al., 2008).”
BackgroundInfluentialEwing sarcoma from molecular biology to the clinic
Dupuy, M., Lamoureux, F., Mullard, M., Postec, A., Regnier, L., Baud’huin, M., Georges, S., Royer, B. B.-L., Ory, B., Rédiní, F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1248753 · Cited by 53
Monument, M. J., Johnson, K. M., McIlvaine, E. J., Abegglen, L. M., Watkins, W. S., Jorde, L. B., Womer, R. B., Beeler, N., Monovich, L., Lawlor, E. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104378 · Cited by 46
“However, contrary to our preliminary understanding of these EWS/FLI-responsive elements, we did not observe a simple linear relationship of increasing gene expression as a function of an increasing number of GGAA motifs [5].”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., & Lessnick, S. L.
- Affiliations
- University of Utah (US)
- Huntsman Cancer Institute (US)
- Department of Human Genetics,
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-07-22
- Volume
- 105
- Issue
- 29
- Pages
- 10149-10154
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2481306
- OpenAlex
- W2027899965
- Cited by
- 297
- References
- 30
- Citations by year
- 2026: 19 · 2025: 18 · 2024: 24 · 2023: 23 · 2022: 24 · 2021: 19 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 14 · 2016: 12 · 2015: 11 · 2014: 13 · 2013: 12 · 2012: 16
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Huntsman Cancer Foundation
- Huntsman Cancer Institute
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL070048)
- National Cancer Institute (K08CA096755, P30CA042014)
- National Institute of General Medical Sciences (R01GM038663, R01GM059290)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- Ewing sarcoma, ETS transcription factors, microsatellite markers, transcription factor target genes, NR0B1, promoter binding, chromosomal translocation, gene expression regulation
- MeSH terms
- Base Sequence, DNA, Neoplasm, Humans, Molecular Sequence Data, Sarcoma, Ewing, Transcription Factors, Transfection, Oncogene Proteins, Fusion, Microsatellite Repeats, Response Elements, RNA-Binding Protein EWS, Cell Line, Tumor, Chromatin Immunoprecipitation, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.